Displaying drugs 12376 - 12400 of 12696 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Veldoreotide | 1123.326 C60H74N12O10 |  | Somatoprim is under investigation for the treatment of Acromegaly. | Amino Acids, Peptides, and Proteins / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Hypothalamic Hormones / Nerve Tissue Proteins / Neuropeptides / Pancreatic Hormones / Peptide Hormones / Peptides / Pituitary Hormone Release Inhibiting Hormones / Proteins |
| Veledimex | 438.612 C27H38N2O3 |  | Veledimex has been used in trials studying the treatment of Glioblastoma Multiforme, Metastatic Breast Cancer, and Anaplastic Oligoastrocytoma. | Heterocyclic Compounds, Fused-Ring |
| Veliflapon | 361.441 C23H23NO3 |  | Veliflapon is under investigation in clinical trial NCT00353067 (Veliflapon (Dg-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina). | Anti-Inflammatory Agents, Non-Steroidal / Lipoxygenase Inhibitors |
| Veliparib | 244.2923 C13H16N4O |  | Not Available | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Velmupressin | 946.58 C42H60ClN11O8S2 |  | Not Available | Not Available |
| Velneperit | 407.45 C17H24F3N3O3S |  | Velneperit has been used in trials studying the treatment of Obesity. | Not Annotated |
| Velpatasvir | 883.019 C49H54N8O8 |  | A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. | Antivirals for treatment of HCV infections |
| Velsecorat | 606.627 C32H32F2N4O6 |  | Velsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation,... | Dioxins and Dioxin-like Compounds / Heterocyclic Compounds, Fused-Ring / Pyrazoles |
| Velusetrag | 504.65 C25H36N4O5S |  | Velusetrag has been used in trials studying the treatment of Gastroparesis and Alzheimer's Disease. It is a highly selective serotonin receptor agonist effective in patients with chronic constipation. It is... | Aza Compounds |
| Vemircopan | 602.493 C29H28BrN7O3 |  | Not Annotated | Not Annotated |
| Vemurafenib | 489.922 C23H18ClF2N3O3S |  | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors / Sulfonamides |
| Venadaparib | 406.461 C23H23FN4O2 |  | Not Available | Not Available |
| Venetoclax | 868.45 C45H50ClN7O7S |  | A BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. | BCL-2 Inhibitor |
| Venglustat | 389.49 C20H24FN3O2S |  | Venglustat is under investigation in clinical trial NCT01674036 (Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men). | Enzyme Inhibitors |
| Venlafaxine | 277.4018 C17H27NO2 |  | A selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of major depression, generalized or social anxiety disorder, and panic disorder. | Agents producing tachycardia |
| Vepafestinib | 474.565 C26H30N6O3 |  | Not Available | Not Available |
| Veralipride | 383.46 C17H25N3O5S |  | Not Annotated | Benzamides and benzamide derivatives |
| Verapamil | 454.6016 C27H38N2O4 |  | A non-dihydropyridine calcium channel blocker used in the treatment of angina, arrhythmia, and hypertension. | ACE Inhibitors and Calcium Channel Blockers / Phenylalkylamine Derivatives |
| Verbenone | 150.221 C10H14O |  | Not Annotated | Bridged-Ring Compounds / Monoterpenes / Terpenes |
| Vercirnon | 444.93 C22H21ClN2O4S |  | Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. It is... | Amides / Sulfones / Sulfur Compounds |
| Verdinexor | 442.325 C18H12F6N6O |  | Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults). | Acids, Acyclic / Acrylates / Amides |
| Verdiperstat | 253.32 C11H15N3O2S |  | Verdiperstat has been used in trials studying the basic science and treatment of Multiple System Atrophy (MSA). | Pyrimidines |
| Verdoheme | 547.405 C30H27FeN4O3 |  | Not Available | Biological Factors / Heterocyclic Compounds, Fused-Ring / Metalloporphyrins / Pigments, Biological / Porphyrins |
| Vericiguat | 426.388 C19H16F2N8O2 |  | A soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure. | Soluble Guanylate Cyclase Stimulator |
| Verinurad | 348.42 C20H16N2O2S |  | Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia. | Antigout Preparations |
Displaying drugs 12376 - 12400 of 12696 in total